Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand

Journal of Neuroimmunology

Volumn 195, Issue 1-2, 2008, Pages 100-107

  Ratto Kim, Silvia ^a,d   Chuenchitra, Thippawan ^b   Pulliam, Lynn ^c,g   Paris, Robert ^d   Sukwit, Suchitra ^b   Gongwon, Siriphan ^d   Sithinamsuwan, Pasiri ^e   Nidhinandana, Samart ^e   Thitivichianlert, Sataporn ^e   Shiramizu, Bruce T ^a   de Souza, Mark S ^d   Chitpatima, Suwicha T ^e   Sun, Bing ^c   Rempel, Hans ^c   Nitayaphan, Sorachai ^b   Williams, Kenneth ^f   Kim, Jerome H ^d,f   Shikuma, Cecilia M ^a   Valcour, Victor G ^a,g  

^a UNIVERSITY OF HAWAII   (United States)

^b Royal Thai Army   (Thailand)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^f BOSTON COLLEGE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HAD; HIV 1; Monocyte markers; Thailand

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; EFAVIRENZ; GPOVIR; HLA DR ANTIGEN; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; RITONAVIR; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADULT; ARTICLE; CELL CULTURE; CELL DEATH; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THAILAND;

ADULT; AIDS DEMENTIA COMPLEX; ANTIGENS, CD4; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MONOCYTES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STATISTICS, NONPARAMETRIC; THAILAND; VIRAL LOAD;

EID: 41949111414     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.11.021     Document Type: Article

References (45)

1. Amirayan-Chevillard N., Tissot-Dupont H., Capo C., Brunet C., and Dignat-George F. Impact of highly active anti-retroviral therapy (HARRT) on cytokine production and monocyte subsets in HIV-infected patients. Clin. Exp. Immunol. 120 (2000) 107-112
2. Anekthananon T., Ratanasuwan W., Techasathit W., Sonjai A., and Suwanagool S. Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study. J. Med. Assos. Thail., Suppl. 87 (2004) 760-767
3. Crowe S., Zhu T., and Muller W.A. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol. 74 (2003) 635-641
4. Davis L.E., Hjelle B.L., Miller V.E., Palmer D.L., Llewellyn A.L., Merlin T.L., Young S.A., Mills R.G., Wachsman W., and Wiley C.A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42 (1992) 1736-1739
5. de Souza M.S., Karnasuta C., Brown A.E., Markowitz L.E., Nitayaphan S., Garner R.P., McNeil J.G., Birx D.L., and Cox J.H. A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North Americans. AIDS Res. Hum. Retrovir. 16 (2000) 1061-1066
6. Eden A., Price R.W., Spudich S., Fuchs D., Hagberg L., and Gisslen M. Immune activation of the central human system is still present after > 4 years of effective highly active antiretroviral therapy. J. Infect. Dis. 196 (2007)
7. Ellery P.J., Tippett E., Chiu Y.L., Paukovics G., Cameron P.U., Solomon A., Lewin S.R., Gorry P.R., Jaworowski A., Greene W.C., Sonza S., and Crowe S.M. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178 (2007) 6581-6589
8. Everall I., and Grant I. Proteomic pointers in HIV neurocognitive disorder. Lancet 363 (2004) 1091-1092
9. Fingerle G., Pforte A., Passlick B., Blumenstein M., Strobel M., and Ziegler-Heitbrock H.W. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82 (1993) 3170-3176
10. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
11. Forton D.M., Allsop J.M., Cox I.J., Hamilton G., Wesnes K., Thomas H.C., and Taylor-Robinson S.D. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. Aids 19 Suppl 3 (2005) S53-S63
12. Gaywee J., Artenstein A.W., VanCott T.C., Trichavaroj R., Sukchamnong A., Amlee P., de Souza M., McCutchan F.E., Carr J.K., Markowitz L.E., Michael R., and Nittayaphan S. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 13 (1996) 392-396
13. Gendelman H.E., L.S, Epstein L., and Swindells S. The Neurology of AIDS (1998), Chapman & Hall, New York
14. Havlir D.V., Koelsch K.K., Strain M.C., Margot N., Lu B., Ignacio C.C., Miller M.D., and Wong J.K. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. J. Infect. Dis. 191 (2005) 1164-1168
15. Hemachudha T., Pyasirisilp S., Tangjanakul C., Rajaboriruz K., Nirustisard S., and Boonma P. Neurologic Manifestation of HIV: Experience in Thailand, Chulalongkorn University Medical Conference, Bangkok, Thailand (1994)
16. Kolson D.L., and Gonzalez-Scarano F. HIV and HIV dementia. J. Clin. Invest. 106 (2000) 11-13
17. Lotrakul M., and Sukanich P. Development of the Thai depression inventory. J. Med. Assos. Thail., Suppl. 82 (1999) 1200-1207
18. Luo X., Carlson K.A., Wojna V., Mayo R., Biskup T.M., Stoner J., Anderson J., Gendelman H.E., and Melendez L.M. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 60 (2003) 1931-1937
19. Maj M., Janssen R., Satz P., Zaudig M., Starace F., Boor D., Sughondhabirom B., Bing E.G., Luabeya M.K., Ndetei D., et al. The World Health Organization's cross-cultural study on neuropsychiatric aspects of infection with the human immunodeficiency virus 1 (HIV-1). Preparation and pilot phase. Br. J. Psychiatry 159 (1991) 351-356
20. Mason C.J., Kitsiripornchai S., Markowitz L.E., Chanbancherd P., Supapongse T., Jugsudee A., Sirisopana N., Chuenchitra C., Torugsa K., VanCott T.C., Michael R.A., and Nitayaphan S. Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 19 (1998) 165-173
21. McCutchan F.E. Understanding the genetic diversity of HIV-1. Aids 14 Suppl 3 (2000) S31-S44
22. Ohagen A., Devitt A., Kunstman K.J., Gorry P.R., Rose P.P., Korber B., Taylor J., Levy R., Murphy R.L., Wolinsky S.M., and Gabuzda D. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J. Virol. 77 (2003) 12336-12345
23. Orandle M.S., Williams K.C., MacLean A.G., Westmoreland S.V., and Lackner A.A. Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. J. Virol. 75 (2001) 4448-4452
24. Otani I., Akari H., Nam K.H., Mori K., Suzuki E., Shibata H., Doi K., Terao K., and Yosikawa Y. Phenotypic changes in peripheral blood monocytes of cynomolgus monkeys acutely infected with simian immunodeficiency virus. AIDS Res. Hum. Retrovir. 14 (1998) 1181-1186
25. Piyasirisilp S., Hemachudha T., Tangjanakul C., Rajaboriruz K., Sirivichayakul S., and Phanuphak P. Cognitive Impairments and Neurological Abnormalities in Self-reliant HIV-infected patients, Chulalongkorn University Medical Conference, Bangkok, Thailand (1994)
26. Polonis V.R., De Souza M.S., Chanbancherd P., Chantakulkij S., Jugsudee A., Loomis-Price L.D., Vancott T.C., Garner R., Markowitz L.E., Brown A.E., and Birx D.L. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies. AIDS Res. Hum. Retrovir. 17 (2001) 69-79
27. Price R.W. Neurological complications of HIV infection. Lancet 348 (1996) 445-452
28. Pulliam L., Gascon R., Stubblebine M., McGuire D., and McGrath M.S. Unique monocyte subset in patients with AIDS dementia. Lancet 349 (1997) 692-695
29. Pulliam L., Herndier B.G., Tang N.M., and McGrath M.S. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87 (1991) 503-512
30. Ranga U., Shankarappa R., Siddappa N.B., Ramakrishna L., Nagendran R., Mahalingam M., Mahadevan A., Jayasuryan N., Satishchandra P., Shankar S.K., and Prasad V.R. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J. Virol. 78 (2004) 2586-2590
31. Roitt I., Brostoff J., and Male D. Immunology (2001), Mosby
32. Sacktor N.C., Wong M., Nakasujja N., Skolasky R.L., Selnes O.A., Musisi S., Robertson K., McArthur J.C., Ronald A., and Katabira E. The INTERNATIONAL HIV Dementia Scale: a new rapid screening test for HIV dementia. Aids 19 (2005) 1367-1374
33. Satishchandra P., Nalini A., Gourie-Devi M., Khanna N., Santosh V., Ravi V., Desai A., Chandramuki A., Jayakumar P.N., and Shankar S.K. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J. Med. Res. 111 (2000) 14-23
34. Shiramizu B., Gartner S., Williams A., Shikuma C., Ratto-Kim S., Watters M., Aguon J., and Valcour V. Circulating proviral HIV DNA and HIV-associated dementia. Aids 19 (2005) 45-52
35. Simmonds P., Zhang L.Q., McOmish F., Balfe P., Ludlam C.A., and Brown A.J. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol. 65 (1991) 6266-6276
36. Sippy B.D., Hofman F.M., Wallach D., and Hinton D.R. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 10 (1995) 511-521
37. Sun B., Rempel H.C., and Pulliam L. Loss of macrophage-secreted lysozyme in HIV-1-associated dementia detected by SELDI-TOF mass spectrometry. Aids 18 (2004) 1009-1012
38. Thieblemont N., Weiss L., Sadeghi H.M., Estcourt C., and Haeffner-Cavaillon N. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25 (1995) 3418-3424
39. Tyor W.R., Glass J.D., Griffin J.W., Becker P.S., McArthur J.C., Bezman L., and Griffin D.E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31 (1992) 349-360
40. Valcour V.G., Sithinamsuwan P., Nidhinandana S., Thitivichianlert S., Ratto-Kim S., Apateerapong W., Shiramizu B.T., Desouza M.S., Chitpatima S.T., Watt G., Chuenchitra T., Robertson K.R., Paul R.H., McArthur J.C., Kim J.H., and Shikuma C.M. Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection. Neurology 68 (2007) 525-527
41. Webster H.K., Pattanapanyasat K., Phanupak P., Wasi C., Chuenchitra C., Ybarra L., and Buchner L. Lymphocyte immunophenotype reference ranges in healthy Thai adults: implications for management of HIV/AIDS in Thailand. Southeast Asian J. Trop. Med. Public Health 27 (1996) 418-429
42. Wesselingh S.L., Power C., Glass J.D., Tylor W.R., McArthur J.C., Farber J.M., Griffin J.W., and Griffin D.E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33 (1993) 576-582
43. Williams K.C., and Hickey W.F. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25 (2002) 537-562
44. Ziegler-Heitbrock H.W., Fingerle G., Strobel M., Schraut W., Stelter F., Schutt C., Passlick B., and Pforte A. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23 (1993) 2053-2058
45. Ziegler-Heitbrock H.W. Definition of human blood monocytes. J. Leukoc. Biol. 67 (2000) 603-606